Ligament Augmentation Market is projected to rise at a CAGR of 5.8% between 2022 and 2032

[263 Pages Report] As per the Future Market Insights’ latest industry analysis, the global ligament augmentation market is set to grow from US$ 41.0 Mn in 2021 to US$ 76.3 Mn by 2032, expanding at a CAGR of 5.8% over the forecast period.

One of the body’s strongest ligaments, the anterior cruciate ligament (ACL) in the knee, is frequently the target of traumatic injuries. Unfortunately, it has a limited capacity for healing, and surgical methods for replacing it are typically accompanied by medical problems. As a result, people opt for ligament augmentation.

Ligament augmentation promotes the healing of these traumatic injuries, and thus, has gained traction in terms of adoption across the globe.

According to a 21-year population study on the incidence of Anterior Cruciate Ligament Tears (ACL) and Reconstruction published by the American Journal of Sports Medicine (2016), high-pivot sporting activities can cause an anterior cruciate ligament (ACL) rupture, with an annual incidence of 68.6 per 100,000 persons. Due to the higher volumes of sports-related activities and accompanying reported injuries, teenagers and young adults make up the majority of those affected by ACL injuries worldwide.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15469

Treatment options for ACL injuries range from non-surgical treatments to a number of surgical techniques, such as autografts or allografts made from the quadriceps tendon, hamstring tendons, or the gold-standard bone-patellar tendon-bone (BPTB). With the growing adoption of artificial tendons and ligaments, and rising research activities for the development of biological grafts, the market for ligament augmentation has witnessed an advancement in growth during the past decade.

Similarly, with expanding healthcare infrastructure around the globe, as well as the growing number of research based upon graft construction using biological and synthetic methods on animal model assessments, the market for ligament augmentation is expected to accelerate at a steady pace over the next ten years.

Key Takeaways from Ligament Augmentation Market Study

  • By product, artificial tendons & ligaments segment held approximately 4% market value share in 2021 and it is likely to grow at 6.2% CAGR through 2032.
  • Based on end user, hospitals segment is projected to grow at 1% CAGR during the forecast period.
  • With presence of trained medical professionals and technologically advanced devices, North America accounts for around 9% of the global ligament augmentation market.
  • European market for ligament augmentation is set to grow at a CAGR of5% during the assessment period.
  • The U.S. will continue to dominate the North American ligament augmentation market, accounting for around 92% share in 2021.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15469

Who is Winning?

Key players employ several strategies for enabling advanced surgical devices and techniques for operating room connectivity. They are focusing on developing new products to expand their portfolios. For instance,

  • In September 2021, Stryker’s Trauma & Extremities division launched the CitrelockTM Tendon Fixation Device System.
  • In May 2021, CorinConnect, the Corin Group’s cloud-based digital ecosystem, updated itself for surgeons to access important analytical data gathered along the orthopaedic journey, providing surgeons with cutting-edge insights for both hip and knee replacement, and enabling them to make more educated choices that will eventually lead to better patient outcomes.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the ligament augmentation devices in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032. The global ligament augmentation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The ligament augmentation market is segmented into three parts based on the product– (artificial tendons & ligaments ligament augmentation devices) and end user (hospitals, ambulatory surgical centres, speciality surgical centres and academic & research institutes), across seven key regions of the world.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15469

Key Players :

  • Stryker Corporation
  • Arthrex,
  • Corin Group; Xiros Ltd (Neoligament)
  • Mathys AG Bettlach,
  • Orthomed S.A.S,
  • Zimmer Biomet.

Key Market Segments Covered in the Ligament Augmentation Industry Research

By Product:

  • Artificial Tendons & Ligaments
  • Ligament Augmentation Devices

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialty Surgical Centres
  • Academic & Research Institutes

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Cotinine Screening Devices Market is projected to increase at a CAGR of ~4.7% From 2022-2029

According to a new market research report by Future Market Insights, the global cotinine screening devices market was valued at ~US$ 429.9 Mn in 2021, and is expected to increase at a CAGR of ~4.7% during the forecast period of 2022-2029. The report scrutinizes the cotinine screening devices market and provides critical insights for the forecast period of 2022-2029. As per the findings of the report, the global cotinine screening devices market is projected to experience a significant growth over the forecast period, which will be set in motion by a slew of factors such as growing focus on ‘value-driven’ healthcare services and high demand for effective screening techniques.

Stakeholders are leveraging newer technologies to offer non-invasive diagnosis, reliability of the screening devices, as well as testing at desired location, in an attempt to align with the trend of convenience, according to the FMI analyst.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8472

Developing Markets to Reflect New Growth Possibilities

Regions such as North America and Europe are expected to hold prominent market share in terms of value. However, developing markets are expected to project lucrative growth in the global cotinine screening devices market in the forecast period of 2022-2029. The exponential rise in workplace screening is one of the key drivers laying new growth alleys for manufacturers of cotinine screening devices to reap benefits from. The economic and technological parity of developing regions with the developed ones is another chief factor estimated to generate steady sales revenue for market players of cotinine screening devices.

Furthermore, rising level of awareness and adoption of products useful in smoking cessation programs is further upholding the lucrativeness of developing markets such as China, India and Brazil. The factors such as growing prevalence of smoking, screening employees for illicit drugs, sporting events, and deciding the health plan premium are anticipated to surge the sales of cotinine screening devices in developing counties.

The burgeoning middle-class population along with multiple compliances created for recruitment in the armed forces are anticipated to increase the potential use cases of cotinine screening devices in 2022 and beyond. The contract manufacturing services available in developing markets coupled with cheap labor force are expected to boost the investment and attractiveness quotient of developing countries, making them no less than hotbeds of opportunities for growth.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8472

End Users to Show Marked Preferences for Cassettes

By device type, the cassettes are expected to hold prominent value shares of the global cotinine screening devices market. This has majorly resulted from the cost effectiveness, ease of screening, quick detection, and portability of these compact cotinine screening devices. The report features the prominent players in the cotinine screening devices market, whose success has been riding on their strong portfolios and regional presence.

The global cotinine screening devices market is significantly consolidated with a chunk of players commanding prominent shares of the market. These players are offering cotinine screening devices under their popular brands such as Accutest®, ALERE ISCREEN®, Reditest®, QuickProfile™, NicCheck™ I, DrugCheck® SalivaScan™, TobacAlert®, among others.  Mergers and acquisitions will remain one of the key part of the growth & expansion strategies of cotinine screening devices market players, with an extensive emphasis on creating newer business models as well as distribution channels.

Cotinine Screening Devices Market, By Category

Device Type

  • Cassettes
  • Strips
  • Reader

By Sample Type

  • Blood Sample
  • Urine Sample
  • Saliva Sample

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/8472

By End-User

  • Hospitals
  • Laboratories
  • Clinics
  • Workplace Screening Centers

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Key Questions Answered in the Report

  • What are cotinine screening devices?
  • What are the key market statistics of the global cotinine screening devices market?
  • Who are the key players of the cotinine screening devices industry?
  • Which device dominates the global cotinine screening devices market?

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Surgical Tourniquets Market is projected to reach US$ 812.2 by 2029

FMI’ analysis expects the surgical tourniquets market to grow at ~8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 381 million in 2019, up from ~US$ 355 million in 2018, according to the latest research from Future Market Insights (FMI).

Surgical tourniquets have long been reliable to establish a bloodless field of operation for surgeons while maintaining a high level of safety for patients. However, the risk of surgical-site infections as well as tourniquet-related injuries, particularly due to the application of high pressures and high pressure gradients to the patient, remains a potential threat to the market growth.

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2254

Sales of Tourniquet Cuffs to Ramp up in 2019

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2018. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2018, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2019.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2018, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2254

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2018. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

Key Segment

By Product Type

  • Tourniquet Systems
    • Single Channel Systems
    • Dual Channel Systems
  • Tourniquet Cuffs
  • Inflatable Cuffs
    • Disposable Cuffs
    • Reusable Cuffs
  • Non-Inflatable Cuffs
    • Disposable Cuffs
    • Reusable Cuffs

By Application

  • Knee Arthroplasty
  • Amputation of Limbs
  • Plastic Surgeries
  • Trauma Cases

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2254

By Region

  • North America
  • Europe
  • Latin America
  • South Asia
  • East Asia
  • Oceania
  • Middle East And Africa
  • Emerging Countries

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Clinical Trials Market Business Opportunities, Industry Growth, Sales Revenue And Industry Expansion Strategies 2029

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.

“The ubiquity digital technologies is evidently growing, as these (including but not limited to ingestible devices, sensors, and wearable health monitors) hold the potential to disrupt the aspects of clinical trials. Digital technologies are revolutionizing the antiquated process of new drug development, even as optimizing the way health data is collected, measured, and assessed”.

According to the study, the clinical trials landscape is witnessing a paradigm shift toward patient centricity, in a bid to incorporate perspective of patients during the clinical trial design. Clinical trial sponsors have aligned their methods with the voice of patients, by launching communication channels during the study’s execution. Key enterprises are adopting unconventional approaches by implementing site-centric method, using operational support systems and technology for bringing studies to the trial-naïve physicians.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-384

Industry Sponsors Account for Majority Clinical Trial Spending

The most remarkable advances in medicine are realized from sponsorships of companies for clinical trials, in the anticipation of turning a profit. A notable percentage of clinical trials being conducted to support approval of vaccines, devices, or drugs, and track their safety, have been industry-sponsored in recent years.

The study estimates industry-sponsored clinical trials to account for ~60% of overall spending in 2019, and in the foreseeable future. Recent studies state that industry-sponsored trials yield positive results compared to academic-run trials, which also account for a significant share of clinical trial spending.

According to FMI, sponsors, such as academic institutes, research institutes and medical centers, are estimated to account for ~30% clinical trial spending in 2019. As the imperativeness of evidence-based therapies continue to be progressively emphasized, most of the randomized clinical trials are driven by the ability of developing profitable new therapies. Guidelines recommended by regulatory bodies for clinical trial enrichment, and risk-based monitoring are likely to lay the groundwork for more targeted approach toward cost-intensive clinical trials.

The study opines that North America and Europe will continue to lead the clinical trials landscape, collectively accounting for ~80% of global spending. These regions present a standardized and favorable environment for the clinical trials landscape, in light of their economic vigor that enables them to benefit from most of the technology disruptions prior to other nations. Pharmaceutical and medical device giants in these two regions are adopting AI for disrupting every stage of the clinical trial, which range from linking studies to eligible patients, to data collection and adherence.

According to the study, opportunities abound for conducting clinical trials in developing economies, such as in East Asia and South Asia, owing to the access to huge patient pool. Sponsors are likely to realize greater success in these regions as low government healthcare budgets represent cost-effective methods of providing patients with access to innovative therapies. Additionally, conducting clinical trials in these regions comes with other broader advantages, including pragmatic & efficient regulatory pathway, and tax incentives for conducting the trials.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-384

Key Segment

By Area

  • Oncology
  • Infectious Disease
  • Metabolic Disorders
  • Cardiovascular
  • Neuroscience
  • Respiratory
  • Others

By Phase

  • Phase 0
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Sponsor

  • Industry-sponsored
  • Government / Public
  • Non-governmental Organizations
  • Others (Academic Medical Centers, Individuals, etc.)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-384

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Deflectable Catheters Market is expected to account for more than US$ 2,400.0 Million in terms of value by the end of 2029.

[243 Pages Report] The deflectable catheters market report also projects a significant growth potential in the market with a CAGR of ~ 4% during the forecast period. Deflectable catheters are used for minimally invasive procedures such as coronary interventions and electrophysiology applications. Due to the upgradation of technology, the core tip can deflect at a certain angle. According to the latest research by FMI, the global deflectable catheters market is expected to account for more than US$ 2,400.0 Mn in terms of value by the end of 2029.

 

Companies Eyeing Untapped Opportunities in Cost-sensitive Regional Market
The current adoption pattern among healthcare professionals favour the use of reposable medical devices, a trend that is most certainly observed in developing countries, to complement the cost factor and availability. In contrast, most of the deflectable catheters used are one-time use products. Factors like blood, debris prevent using reposable deflectable catheters in operations as critical as electrophysiology.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5852

The usage of reposable deflectable catheters is significantly higher in developing economies with inadequate resources, where the cost of treatment can be significantly high, which is unfavourable for patients from poor backgrounds. The present cost structure with the use of reposable deflectable catheters makes it feasible for a sizeable population to opt for low-cost treatment options, which help boost the adoption rate, and thereby expand the consumer pool.

At present, there are only a few companies offering reposable deflectable catheters, and none of the major players are into developing reposable devices. As per the report, a comparatively smaller company, CathRx, has a similar reposable product, Khelix, which is considered to be the first ‘reposable’ diagnostic and therapeutic catheter for the treatment of cardiac arrhythmias.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5852

Acquisitions & Collaborations Playing Decisive Role in Shaping Deflectable Catheters Market StructureThe affective adjustments and development observed in the parent market influences the deflectable catheters market. The recent trend of involving digital methods for diagnosing cardiac problems is also changing the treatment pattern. All these trends are more governed by the top market leaders in the cardiology market. With abundant resources and investment plans, they manipulate the industry in a way in which no other smaller or regional manufacturer is capable of keeping pace with them.

The trend of acquisition and forming a strategic partnership is positive delivering financial results. For example, Abbott’s acquisition of St. Jude Medical resulted in the consolidation of the 2nd and 4th largest cardiology market players. Moreover, the acquisition of specific treatment technologies has also been observed in the deflectable catheter market, and there has been an increase in the number of players expanding their product portfolio for the treatment of atrial fibrillation/atrial flutter.

Deflectable Catheters Market: Segmental AnalysisOn the basis of product type, the deflectable catheters market has been segmented into uni-directional deflectable catheters, bi-directional deflectable catheters, and multi-directional deflectable catheters. Bi-directional deflectable catheters lead the market due to their high adoption rate and availability.

Based on application, the deflectable catheters market has been segmented into coronary interventions, electrophysiology, diagnostics imaging, and peripheral interventions. In terms of revenue, the electrophysiology segment is expected to have a major share in the deflectable catheters market due to an increase in the number of procedures being carried out by deflectable catheters.

On the basis of end user, the deflectable catheters market has been categorised into hospitals, office-based clinics, ambulatory surgical centres, and independent catheterisation labs. Independent catheterisation labs are expected to witness significant growth, which is driven by an increase in the number of the same.

Some of the key players in the deflectable catheters market include Medtronic Plc, Merit Medical Systems, JOHNSON & JOHNSON, Teleflex Incorporated, Boston Scientific Corporation, Biomerics LLC, OSYPKA AG, Abbott, Japan Lifeline Co., CathRx Ltd., and Biotronik SE & Co. KG.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5852

Key Segments Of Deflectable Catheters Industry Survey Deflectable Catheters Market by Product Type:

  • Uni-Directional Deflectable Catheters
  • Bi-Directional Deflectable Catheters
  • Multi-Directional Deflectable Catheters

Deflectable Catheters Market by Application:

  • Deflectable Catheters for Coronary Interventions
  • Deflectable Catheters for Electrophysiology
  • Deflectable Catheters for Diagnostics Imaging
  • Deflectable Catheters for Peripheral Interventions

Deflectable Catheters Market by End User:

  • Deflectable Catheters for Hospitals
  • Deflectable Catheters for Office-based Clinics
  • Deflectable Catheters for Ambulatory Surgical Centres
  • Deflectable Catheters for Independent Catheterization Labs

Deflectable Catheters Market by Region:

  • North America Deflectable Catheters Market
  • Latin America Deflectable Catheters Market
  • Europe Deflectable Catheters Market
  • East Asia Deflectable Catheters Market
  • South Asia & Pacific Deflectable Catheters Market
  • Middle East & Africa (MEA) Deflectable Catheters Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Volatile Corrosion Inhibitor Bags Market Insights By Type, Industry, Application & End-User | FMI

Between 2022 and 2032, the demand for volatile corrosion inhibitor bags is anticipated to grow at a strong CAGR of roughly 6.4%. Growth can be attributed to the increasing usage of volatile corrosion inhibitor bags for preserving corrosion-sensitive products during storage and shipping in a variety of end use industries, including automotive, medical devices, and electronics.

Manufacturers are coming up with new anti-corrosion goods such volatile corrosion inhibitor bags that not only prevent corrosion but also aid to extend the life of packaged products as the search for developing innovative packaging solutions intensifies.

Volatile corrosion inhibitor bags are creative packaging solutions made possible by impregnating packaging materials like paper and plastic with volatile corrosion inhibitors (VCI).

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9171

How will the Asia Pacific Excluding Japan (APEJ) market experience growth?
According to FMI, the market for volatile corrosion inhibitor bags in Asia Pacific Excluding Japan (APEJ) is anticipated to grow at a relatively higher CAGR over the course of the forecast period as a result of the rapidly expanding end-use industries, rising consumer awareness, and soaring demand for protective packaging solutions.

China continues to lead the pack in the APEJ volatile corrosion inhibitor bags market, and this upward trend is probably here to stay. One of the top exporters of metallic goods, including electrical and automotive components, is the nation.

What Makes Western Europe an Attractive Market for Volatile Corrosion Inhibitor Bags?

Western Europe accounted for a major chunk of the global volatile corrosion inhibitor bags market in 2022 and is expected to register a healthy growth rate during the assessment period. Growth in the market is attributable to the rising export of automotive, military and medical products and equipment by countries like Germany and the United Kingdom.

Most of the metallic component manufacturers across the region prefer to use volatile corrosion inhibitor bags over protective coatings due to their various attractive benefits. These anticorrosion bags not only help them to protect the products from dust, gases, and moisture but also reduce the overall costs.

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-9171

Market Competition

Some of the key participants present in the global volatile corrosion inhibitor bags market include

  • Royco Packaging, Inc.,
  • Alfa Solution AS,
  • Armor Protective Packaging,
  • Protective Packaging Corporation,
  • Daubert Cromwell, Inc.,
  • Rustx, and
  • Heritage Packaging among others.

The global volatile corrosion inhibitor bags market is highly competitive in nature due to the large presence of regional and domestic players. Leading players are continuously adopting growth strategies such as new product launches, capacity expansion, partnerships, and move towards online shopping platforms to gain a competitive edge in the market. Besides this, they are collaborating with end-use industries to supply them with customized products for specific applications.

Key Segments Profiled in the Volatile Corrosion Inhibitor Bags Industry Survey

By Material Type:

  • Plastic Bags
  • Paper Bags

By Layer:

  • Mono-layer
  • Multi-layers

By Product Type:

  • Flat Bags
  • Gusseted Bags
  • Zipper Bags
  • Others

By End Use:

  • Automotive
  • Electrical and Electronics
  • Military
  • Aerospace
  • Medical Devices
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-9171

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com 
Browse Latest Market reports: https://www.futuremarketinsights.com/reports

Female Stress Urinary Incontinence Treatment Devices Market of US$ 1.07 Billion by 2029

[195 Pages Report] The rising prevalence of urinary incontinence in pregnant women, stress urinary incontinence due to diabetes, gynaecology disorders, and urinary incontinence in postmenopausal women are some of the major factors propelling the growth of the female stress urinary incontinence treatment devices market. Several other risk factors that increase the risk of developing stress urinary incontinence in women include high body weight, type of childbirth, age, pelvic surgery, etc.

 

A few medical conditions such as enlarged prostate, muscle damage, excess urine formation, multiple sclerosis, Parkinson’s disease, spinal cord injury, and loss of storage capacity in the rectum are also expected to boost the incidence of stress urinary incontinence among women, which is fuelling the demand for female stress urinary incontinence treatment devices.

The practice of using female stress urinary incontinence treatment devices has changed dramatically over the past decade. The number of procedures undertaken appears to be increasing, and the shift in relative numbers of different procedures has been remarkable. For instance, in England, the annual number of operations undertaken using female stress urinary incontinence treatment devices between 1997-1998 and 2005-2006 increased by 28%, despite a reduction of over 90% in the number of colposuspension and needle suspension procedures.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-2533

Healthy Revenue Growth Projected through 2029

According to latest research by FMI, the global female stress urinary incontinence treatment devices market is estimated to have accounted for ~ US$ 560 Mn in terms of value in 2018. The report on the female stress urinary incontinence treatment devices market further projects that the female stress urinary incontinence treatment devices market is likely to grow at a CAGR of ~ 6% during the period 2019-2029.

However, due to the presence of wide range of products in the female stress urinary incontinence treatment devices market, small players are gaining interest and are selling their products at a lower price. Increase in the penetration of private-label brands at much lower prices is expected to decrease the average overall price of female stress urinary incontinence treatment devices. This is likely to restrain the growth of the global female stress urinary incontinence treatment devices market, as it is likely to hamper the demand for expensive products.

Rapid changes have taken place in developing countries over the past few years. The improper implementation of regulatory guidelines and the lack of proper healthcare infrastructure in developing regions, such as the Middle East & Africa and Latin America, are among factors that are expected to restrain the growth of the female stress urinary incontinence treatment devices market.

50% Revenue Shares Accounted by North America

The female stress urinary incontinence treatment devices market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa. North America, followed by Europe, is a prominent region in the global female stress urinary incontinence treatment devices market. North America accounted for a revenue share of about 50% in 2018 in the female stress urinary incontinence treatment devices market. Europe also accounted for a prominent revenue share, and is followed by East Asia in the female stress urinary incontinence treatment devices market.

The female stress urinary incontinence treatment devices market report tracks some of the key companies operating in female stress urinary incontinence treatment devices market, such as Boston Scientific Corporation, BD, Coloplast Corporation, Caldera Medical, and Ethicon US LLC (Johnson & Johnson Services, Inc.). Majority of the key regional players in the female stress urinary incontinence treatment devices market highly focused on expanding their product connectivity and reach with the help of domestic distributors of female stress urinary incontinence treatment devices. Moreover, the manufacturers of female stress urinary incontinence treatment devices are focused to strengthening their businesses in high-growth markets, such as India, Japan, and China, by expanding their distribution and sales channels.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2533

Key Segments Of Female Stress Urinary Incontinence Treatment Devices Industry Survey Female Stress Urinary Incontinence Treatment Devices Market by Product Type:

  • Sling Systems
    • Mid-Urethral Slings
    • Sub-Urethral Slings
  • Pessaries
  • Artificial Urinary Sphincters (AUS)
  • Injectable Urethral Bulking Agents

Female Stress Urinary Incontinence Treatment Devices Market by End Use:

  • Female Stress Urinary Incontinence Treatment Devices for Hospitals
  • Female Stress Urinary Incontinence Treatment Devices for Gynaecological Clinics
  • Female Stress Urinary Incontinence Treatment Devices for Homecare Settings

Female Stress Urinary Incontinence Treatment Devices Market by Region:

  • North America Female Stress Urinary Incontinence Treatment Devices Market
  • Latin America Female Stress Urinary Incontinence Treatment Devices Market
  • Europe Female Stress Urinary Incontinence Treatment Devices Market
  • East Asia Female Stress Urinary Incontinence Treatment Devices Market
  • South Asia & Pacific Female Stress Urinary Incontinence Treatment Devices Market
  • Middle East & Africa (MEA) Female Stress Urinary Incontinence Treatment Devices Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Aortic Stents Grafts Market to reaching a valuation of around 2.8 Billion by 2028

[215 Pages Report] [215 Pages Report] The global Aortic Stents Grafts Market is forecast to total US$ 2.15 Bn in 2022. With increasing preference for minimally invasive procedures, the overall market is projected to grow at 4.5% CAGR, reaching a valuation of around 2.8 Bn by 2028.

 

Future Market Insights delivers key insights and presents a revised forecast of the global aortic stent grafts market for a 10-year period from 2018 to 2028 in the report titled “Aortic Stent Grafts Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028.” The revision in the market size and volume forecasts has been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of the key market participants. In terms of revenue, the global aortic stent grafts market is projected to expand at a 7.6% CAGR over the forecast period of 2018–2028.

North America is expected to contribute a high revenue share in the global aortic stent grafts market over the forecast period. North America is witnessing a large demand for aortic stent grafts due to high adoption of endovascular repair surgeries, which is expected to boost the growth of the aortic stent grafts market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-865

The global market is segmented based on product type, end users and region. Based on the product type the market is segmented into abdominal aortic stent graft and thoracic aortic stent grafts. Abdominal aortic stent graft product type segment is expected to represent high revenue share in the global aortic stent grafts market. The thoracic aortic stent graft segment is expected to gain significant share in the forecast period due to increasing focus of the manufacturers on product launch for TEVAR procedures. Based on end users, the market is segmented into the hospitals and ambulatory surgical centers/outpatient surgical centers. Among both the end users, the hospitals is expected to be the leading segment the market.

New product launches with improved stent graft designs are expected to provide enormous opportunities for the growth of the aortic stent grafts market and fulfil the demand from surgeons to overcome complications during surgeries. Increasing government initiatives to reduce the burden of abdominal aortic aneurysm, favourable recommendation and regulatory approvals, mergers, and acquisitions among manufacturers are the key market trends, which are expected to boost the growth of aortic stent grafts market.

Increasing prevalence of aortic aneurysm among the older population, favourable reimbursement policies, adoption of new minimally invasive technologies are the major factors expected to impel the growth of the aortic stents grafts market. Increasing number of government screening programs for people over 65 age has provided huge growth opportunities for the manufacturers operating in the aortic stent grafts market. However, product recalls and lack of skilled healthcare professionals are factors hindering the growth of the aortic stent grafts market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-865

The market for aortic stent grafts market is consolidated with large number of major players operating in the global market. Examples of some of the key players identified in global aortic stent grafts market are

  • Cook Medical Inc.
  • W.L. Gore & Associates
  • MicroPort Scientific Corporation Inc.
  • Medtronic Plc.
  • Lombard Medical Inc.
  • Endologix
  • INC.
  • Terumo Corporation Inc.
  • Cardinal Health Inc.
  • Becton
  • Dickinson and Company
  • Cryolife Inc.
  • Lombard Medical Inc.

Aortic Stents Grafts Market By Category

Product Type:

  • Abdominal Aortic Stent Graft
  • Thoracic Aortic Stent Graft

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatient Surgical Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

High Flow Nasal Cannula Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2030

Market research company Future Market Insights’ projections on the high flow nasal cannula market reveal that the market is slated to be valued at ~US$ 18 Bn by 2030. Technological advancements by key market players are also anticipated to burgeon the high-flow nasal cannula market. Moreover, clinical trials for evaluating new application areas shall open up new avenues for the market. According to the Global Burden of Disease Study, 2013, around 300 million people suffered from COPD during that year. This is attributed to growing addiction for smoking, deteriorating air quality and rising pollution across the globe. The prevalence of respiratory disorders will further boost market prospects.

Growing prevalence of respiratory disorders have led to an increase in the uptake of high-flow nasal cannula (HFNC) devices. The Center for Disease Control and Prevention (CDC) acknowledges the high-flow nasal cannula oxygenation therapy as a standard recommended therapy across the United States, especially during the COVID-19 pandemic.

Following this development, healthcare providers are facilitating extensive research on how to better integrate this technology in providing relief for severely infected patients. In the pre-COVID-19 scenario, HFNC was being administered to patients with acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). These conditions were responsible for a majority of respiratory casualties.

Such extensive applications to correct respiratory anomalies is anticipated to sustain the market demand for HFNC treatment solutions and devices throughout the forecast period.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11269

“Rising incidence of respiratory problems is anticipated to steer the high-flow nasal cannula market towards a positive growth trajectory. Moreover, the coronavirus pandemic is anticipated to leverage market prospects, owing to its suitability in oxygen delivery to patients,” opines an FMI analyst.

Key Takeaways from FMI’s High Flow Nasal Cannula Market Report

  • North America and Europe shall capture half of the HFNC market
  • E-commerce to be the most widely used channels for HFNC device delivery due to preference for contactless transactions
  • Homecare settings to extensively use HFNC treatment devices
  • Infant bronchitis and pneumocephalus to generate fertile ground for HFNC treatment during 2020-2030
  • Single-use nasal cannulas gain traction during the COVID-19 crisis
  • High flow nasal cannula market shall expand at over 12% CAGR in 2020

High Flow Nasal Cannula Market- Key Trends

  • Continuous product launches to flood the global HFNC market as vendors look to acquire a competitive edge over their rivals
  • Smooth oxygen delivery of heated, humidified oxygen at a flow rate of 60 liters per minute makes HFNC an ideal treatment method for respiratory patients
  • Partnerships and collaborations with research institutions and hospitals are increasing in order to provide treatment for severely affected COVID-19 patients

High Flow Nasal Cannula Market: Region-wise Analysis

  • Single-use HFNC devices are gaining traction across the German, Japanese and English markets respectively
  • The United States market shall expand at over 10% CAGR by 2020-end
  • Growing healthcare literacy amongst the population shall propel HFNC usage in India and China
  • Japan dominates the East-Asian high flow nasal cannula market

For information on the research approach used in the report, request methodology@ https://www.futuremarketinsights.com/askus/rep-gb-11269

High Flow Nasal Cannula Market: Competitive Landscape

The high flow nasal cannula market is characterized by the presence of numerous players, making the market highly fragmented. The players are capitalizing on new product launches to acquire a market foothold.

For instance, in Jan 2019, ResMed unveiled its MOBI portable oxygen concentrator across the US market to address patients suffering from chronic obstructive pulmonary disease (COPD). Later that year, in May 2019, Fisher & Paykel Healthcare Ltd. launched the Optiflow 3S nasal cannula technology.

Likewise, Teleflex launched the Hudson RCI Comfort Flo Plus Cannula which concentrates on administering oxygen to the upper airway dead space, providing a greater level of comfort.

High Flow Nasal Cannula Market Taxonomy

Component

  • Air/Oxygen Blender
  • Active Humidifier
  • Nasal Cannulas
  • Heated Inspiratory Circuit
  • Consumables

Medical Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bronchiectasis
  • Carbon Monoxide Toxicity
  • Sleep Apnea
  • Acute Heart Failure
  • Others

End User

  • Hospitals
  • Specialty Clinics
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Homecare Settings

Buy Now@ https://www.futuremarketinsights.com/checkout/11269

Region/Country

North America

  • U.S
  • Canada

Latin America

  • Argentina
  • Brazil
  • Mexico
  • Rest of LATAM

Europe

  • EU-5
  • Russia
  • Rest of Europe

South Asia

  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Rest of South Asia

East Asia

  • China
  • Japan
  • South Korea

Oceania

  • Australia
  • New Zealand

Middle East & Africa (MEA)

  • GCC
  • South Africa
  • Rest of MEA

Want more insights?

High flow nasal cannula market, a new study from Future Market Insights, states the indications of high flow nasal cannula from 2015 to 2019 and presents demand projections from 2020 from 2030 on the basis of components (air/oxygen blender, active humidifier, nasal cannulas, heated inspiratory circuit, and consumables), application (acute respiratory failure, chronic obstructive pulmonary disease (COPD), bronchiectasis, carbon monoxide toxicity, sleep apnea, acute heart failure, and others), and end user (hospitals, specialty clinics, long-term care centers, ambulatory care centers, and homecare setting) across seven prominent regions.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

High Barrier Film Packaging Market to be US$ 28,569.4 Million from 2022 to 2032 | Future Market Insights

Hectic routine and the resulting convenience products requirement, along with the microwave cooking popularity has contributed to rising use of microwave-able retort ready meals packed in stand-up pouches and trays.

Flexible packaging solutions including, retort pouches, reseal able zippers, and spouts are replacing rigid pack designs, such as glass jars and metal tins. Customers’ growing requirement for product safety and convenience are encouraging increment in high-barrier packaging films demand. The global market will expand at a steady CAGR by the end of the forecast period.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2138

High Barrier Film Packaging Market – Key Developments and Trends

Manufacturers are developing high barrier packaging films, especially for shelf-ready products, that offer ease of peel. For instance, Schur Flexibles Holding provides advanced high barrier packaging films for case-ready and processed products.

EVOH-derived shrink films are majorly preferred material, as they offer excellent protection from UV rays and extreme temperatures.

Manufactures all over the world are shifting to innovative packaging methods such as Modified Atmospheric Packaging (MAP), Aseptic Packaging, and Vacuum Skin Packaging, owing to greater benefits compared to traditional packaging methods.

Moreover, they are creating their proprietary packaging solutions such as Besela barrier film technologies that incorporate modified Poly Acrylic Acid(PAA) coating on PET base films.

Customer’s requirement for food with high quality and a longer shelf life has prompted the growth of progressively advanced multilayer film structures.

Reprocessing multi-material structures is an existing problem, as these are hard to isolate with the equipment installed in present-day materials recovery facilities (MRF). Conversely, new solutions are getting commercially accessible for reprocessing multilayer films.

High Barrier Film Packaging Market – Growth Restraints

While these packaging films have high application scope in pharmaceutical packaging and food & beverage packaging, the plastic waste generated worldwide has compelled governments in several nations to ban usage of plastic films.

Globally, about 348 million tons of plastic is produced, of which, merely 10% is goes to recycling plants. Moreover, recycling of high barrier film packaging is cost-intensive and complicated, thus, narrowing the profit margins of manufacturers.

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-2138

COVID-19 Impact Analysis

The COVID-19 pandemic has raised concerns regarding hygiene and safety of food products and drugs. Although for the short term, the sustainability aspect of various packaging companies is receiving a lower priority.

The pandemic is bringing back the single-use plastic packaging to the forefront due to their better hygiene measure, however, outweighing concerns about recyclability and plastic-waste leakage into the oceans and lands.

As such, players in high barrier film packaging are rethinking sustainability along with hygiene and consumers’ safety concerns. Choice of materials and packaging designs are expected to have a measurable impact on the high barrier film packaging market amid the pandemic.

High Barrier Film Packaging Market – Region-wise Analysis

Europe and North America would remain at the driver’s seat in the high barrier film packaging market, based on manufacturing capacity and demand. Evolving trends such as on-the-go flexibility and at-home usage are fueling the demand for packaged foods and beverages in both the regions.

Presence of well-established digital ecosystem continues to attract stakeholders. Furthermore, the flexible packaging industries in North America and Europe are outpacing the rigid packaging market, given rising concerns regarding ecological burden.

Moving ahead, the high barrier film packaging market in Asia Pacific (APAC) is expected to witness rapid, owing to surging consumption of ready-to-eat (RTE) food products.

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-2138

High Barrier Film Packaging Market: Competitive Analysis

Market players are aggressively focusing on enhancing their global footprint by mergers & acquisitions (M&A), and enhancing product portfolios.

  • In order to boost its ability to develop eco-friendly, clean, safe liners, Mondi PLC has set up its new unit in Styria to develop high-barrier, side-folded tubes for FIBCs. This further enables the company to make these films in several structures, from PE/EVOH to seven-layered PE/PA/EVOH, and PE to PE/PA structures.
  • Amcor has developed AmLite Ultra Recyclable prepared from more sustainable high-barrier polyolefin film. The new films package a variety of food, pharmaceutical, and home, and personal care products, and are able to be reprocessed in existing polyolefin recycling streams.
  • Huhtamaki has begun its flexible packaging production in Egypt. The investment marks its entrance into the production of flexible packaging in Africa. Additionally, the manufactured products will be exported to Europe and other African nations.

Major companies in the global market are

  • Bemis Company, Inc.
  • Amcor Limited (Australia)
  • American Pouch
  • Ampac Oliver-Tolas
  • Sealed Air
  • Krehalon
  • Flair Flexible
  • HPM Global, Inc.
  • Constantia Flexibles
  • Winpak Limited
  • Janco Inc.
  • MULTIVAC
  • Wipak Group Dupont
  • BERNHARDT Packaging

Other prominent companies include 3D Packaging, Sonoco, Prairie State Group, Perlen Packaging, Shako Flexipack, and ClearBags,.

Region

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com 
Browse Latest Market reports: https://www.futuremarketinsights.com/reports